Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Fei Yang
Affiliation
Oregon Health & Science University
ORCID
Career Start Year
2002
Papers
29
H Index
11
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37170730
Study of 43 SLE patients with autoimmune liver cirrhosis: emphasis on clinical features and differences from lupus without cirrhosis.
Int J Rheum Dis
2023
37088803
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.
Blood Cancer J
2023
34482403
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Blood
2022
35802949
A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia.
Cancer Genet
2022
36568279
A novel <i>BCL11A</i> polymorphism influences gene expression, therapeutic response and epilepsy risk: A multicenter study.
Front Mol Neurosci
2022
33769269
Kimura's disease: clinical characteristics, management and outcome of 20 cases from China.
Clin Exp Rheumatol
2022
35258401
Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcome.
Leuk Lymphoma
2022
34874823
Clinical characteristics of IgG4-related respiratory disease patients: a large Chinese cohort study.
Clin Exp Rheumatol
2022
32793960
Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study.
Rheumatology (Oxford)
2021
33600452
Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.
PLoS One
2021
33568210
Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease.
Arthritis Res Ther
2021
34496019
A novel activating JAK1 mutation in chronic eosinophilic leukemia.
Blood Adv
2021
34277657
Diagnosis of <i>Mycobacterium tuberculosis</i> Septic Shock in Patients With Anti-synthetase Syndrome Based on Next-Generation Sequencing: A Case Report and Literature Review.
Front Med (Lausanne)
2021
34093952
Primary renal NUT carcinoma identified by next-generation sequencing: a case report and literature review.
Int J Clin Exp Pathol
2021
34001958
Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients.
Sci Rep
2021
33415580
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
Invest New Drugs
2021
32463619
Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States.
Clin Transl Gastroenterol
2020
32097488
Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Rheumatology (Oxford)
2020
31848884
Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Mol Diagn Ther
2020
32386024
Effect of deletion of SUMOylation on dendritic cell function in septic mice and its role in sepsis.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
2020
32211343
Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Encephalitis and Meningitis: A Large, Prospective Case Series of 213 Patients.
Front Cell Infect Microbiol
2020
31026597
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
J Mol Diagn
2019
31124175
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol
2019
29959414
Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS.
Leukemia
2018
27124934
Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Am J Clin Pathol
2016
23666688
Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
Methods Mol Biol
2013
21908430
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Blood
2011
21860020
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.
Blood
2011
11774355
Using mRNA expression profiling to determine anticancer drug efficacy.
Cytometry
2002
1 - 29 of 29
Column Actions
Search
Recommended Authors
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year
2017
Number of shared co-authors
18
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year
2012
Number of shared co-authors
3
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year
2011
Number of shared co-authors
6
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year
2010
Number of shared co-authors
1
Markus Ball
Institute of Pathology, Heidelberg University Hospital
Career Start Year
2010
Number of shared co-authors
2
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year
2009
Number of shared co-authors
0
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2009
Number of shared co-authors
0
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
1
Felicitas Thol
Hannover Medical School
Career Start Year
2007
Number of shared co-authors
3
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
2
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
2
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year
2004
Number of shared co-authors
4
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year
2004
Number of shared co-authors
0
Anna L Brown
Adelaide Medical School, University of Adelaide
Career Start Year
2003
Number of shared co-authors
4
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
2003
Number of shared co-authors
3
Thomas Ernst
Universitatsklinikum Jena
Career Start Year
2002
Number of shared co-authors
2
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year
2001
Number of shared co-authors
3
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
3
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
3
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year
1998
Number of shared co-authors
1
Jason D Merker
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
2
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year
1998
Number of shared co-authors
5
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year
1996
Number of shared co-authors
5
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
1
Lucy A Godley
The University of Chicago
Career Start Year
1994
Number of shared co-authors
7
Michael Heuser
Hannover Medical School
Career Start Year
1993
Number of shared co-authors
4
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
4
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
0
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year
1989
Number of shared co-authors
3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Richard D Press
Oregon Health and Science University
Co-authored papers
12
Guang Fan
Oregon Health and Science University
Co-authored papers
5
Brian J Druker
Oregon Health & Science University
Co-authored papers
3
Tauangtham Anekpuritanang
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
3
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers
3
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers
3
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
3
Nicola Long
Oregon Health and Science University
Co-authored papers
2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers
2
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers
2
Prapti Patel
The University of Texas Southwestern Medical Center
Co-authored papers
1
Stephen B Howell
Moores Cancer Center and Department of Medicine, University of California
Co-authored papers
1
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Jose Solis-Ruiz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers
1
Ronan Swords
Oregon Health and Science University
Co-authored papers
1
Jason Gotlib
Stanford University School of Medicine
Co-authored papers
1
Uma Borate
The Ohio State University
Co-authored papers
1
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Allison M Bock
Mayo Clinic
Co-authored papers
1
Matthew J Walter
Washington University School of Medicine in St. Louis
Co-authored papers
1
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Kavin B Vasudevan
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers
1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
1
Yassmine Akkari
Association for Molecular Pathology
Co-authored papers
1
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers
1
Srinidhi Radhakrishnan
University of Texas Southwestern Medical Center
Co-authored papers
1
Ujwal Shinde
Oregon Health & Science University
Co-authored papers
1
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
1
1 - 30